{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:10:47Z","timestamp":1782972647261,"version":"3.54.5"},"reference-count":30,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabet Med"],"abstract":"Abstract<\/jats:title>\n \n Aims<\/jats:title>\n Dyslipidaemia in youth with type 1 diabetes mellitus (T1D) is emerging as an important modifiable cardiovascular risk factor. International consensus guidelines to screen this entity have evolved over time. To further evaluate this in an Australian context, we investigated adherence to such guidelines over the course of patient care. Additionally, once a diagnosis of dyslipidaemia was made, the trajectory and clinical management of these patients were explored.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A retrospective audit was undertaken in paediatric patients diagnosed with T1D. Clinical and ancillary laboratory data were collected.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of the 335 patients identified, 263 (78%) followed initial lipid screening guidelines. Mean interval of testing was 17\u2009months (SD 8\u2009months), rather than the recommended 5\u2010year interval. One or more abnormal lipid test parameters were identified in 55% (\n n<\/jats:italic>\n \u2009=\u2009183\/335) of individuals. Average age at diagnosis of dyslipidaemia was 15.6\u2009years (SD 2.0\u2009years). In this cohort, 69 individuals (25%, 69\/280) had an abnormal low\u2010density lipoprotein\u2010cholesterol (LDL\u2010C) level, of whom 15 individuals (\n n<\/jats:italic>\n \u2009=\u200915\/69, 22%) had a level >\u20093.4\u2009mmol\/L, and 4 individuals had a level >\u20094.1\u2009mmol\/L (4\/69, 6%). Only 1 of the 69 individuals was referred to a dietician. No patient was commenced on pharmacotherapy.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Overall, our data indicate low adherence to international guidelines for dyslipidaemia screening and management. The reasons for this cannot be defined by a retrospective study but may reflect low clinician confidence, competing therapeutic priorities or difficulty in following current guidelines.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/dme.70382","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:50:07Z","timestamp":1782967807000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperlipidaemia in youth with type 1 diabetes: Are current guidelines clinically useful?"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6404-8519","authenticated-orcid":false,"given":"Farrah","family":"Rodrigues","sequence":"first","affiliation":[{"name":"Murdoch Children's Research Institute Melbourne Victoria Australia"},{"name":"Department of Endocrinology and Diabetes Royal Children's Hospital Melbourne Victoria Australia"},{"name":"Department of Paediatrics University of Melbourne Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"White","sequence":"additional","affiliation":[{"name":"Murdoch Children's Research Institute Melbourne Victoria Australia"},{"name":"Department of Endocrinology and Diabetes Royal Children's Hospital Melbourne Victoria Australia"},{"name":"Department of Paediatrics University of Melbourne Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele A.","family":"O'Connell","sequence":"additional","affiliation":[{"name":"Murdoch Children's Research Institute Melbourne Victoria Australia"},{"name":"Department of Endocrinology and Diabetes Royal Children's Hospital Melbourne Victoria Australia"},{"name":"Department of Paediatrics University of Melbourne Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"4","key":"e_1_2_10_2_1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/dc16-2193","article-title":"Predictors of dyslipidemia over time in youth with type 1 diabetes: for the SEARCH for diabetes in youth study","volume":"40","author":"Shah AS","year":"2017","journal-title":"Diabetes Care"},{"issue":"2","key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jpeds.2006.10.054","article-title":"Longitudinal lipid screening and use of lipid\u2010lowering medications in pediatric type 1 diabetes","volume":"150","author":"Maahs DM","year":"2007","journal-title":"J Pediatr"},{"issue":"8","key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/pedi.13444","article-title":"ISPAD clinical practice consensus guidelines 2022: microvascular and macrovascular complications in children and adolescents with diabetes","volume":"23","author":"Bjornstad P","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"23","key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMoa022314","article-title":"Intensive diabetes therapy and carotid intima\u2010media thickness in type 1 diabetes mellitus","volume":"348","author":"Nathan DM","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"e_1_2_10_6_1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archpedi.161.2.159","article-title":"Serum lipids and glucose control: the SEARCH for diabetes in youth study","volume":"161","author":"Petitti DB","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"e_1_2_10_7_1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2337\/dc08-1641","article-title":"Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes","volume":"32","author":"Marcovecchio ML","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpeds.2012.06.006","article-title":"Glucose control predicts 2\u2010year change in lipid profile in youth with type 1 diabetes","volume":"162","author":"Maahs DM","year":"2013","journal-title":"J Pediatr"},{"issue":"3","key":"e_1_2_10_9_1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2337\/dc08-1775","article-title":"Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for diabetes in youth case\u2010control study","volume":"32","author":"Guy J","year":"2009","journal-title":"Diabetes Care"},{"issue":"10146","key":"e_1_2_10_10_1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register\u2010based cohort study","volume":"392","author":"Rawshani A","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"13","key":"e_1_2_10_11_1","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIR.0000000000000034","article-title":"Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association","volume":"130","author":"Ferranti SD","year":"2014","journal-title":"Circulation"},{"issue":"10138","key":"e_1_2_10_12_1","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/S0140-6736(18)30314-3","article-title":"Trends in cause\u2010specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data","volume":"391","author":"Gregg EW","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"14","key":"e_1_2_10_13_1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long\u2010term complications in insulin\u2010dependent diabetes mellitus","volume":"329","author":"Nathan DM","year":"1993","journal-title":"N Engl J Med"},{"issue":"5","key":"e_1_2_10_14_1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30\u2010year follow\u2010up","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2337\/diacare.24.6.1053","article-title":"Lipid and blood pressure treatment goals for type 1 diabetes: 10\u2010year incidence data from the Pittsburgh epidemiology of diabetes complications study","volume":"24","author":"Orchard TJ","year":"2001","journal-title":"Diabetes Care"},{"issue":"10","key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S2213-8587(18)30035-4","article-title":"Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?","volume":"6","author":"Bjornstad P","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial","volume":"292","author":"Wiegman A","year":"2004","journal-title":"JAMA"},{"issue":"20","key":"e_1_2_10_18_1","first-page":"257","article-title":"ISPAD clinical practice consensus guidelines 2014. Microvascular and macrovascular complications in children and adolescents","volume":"15","author":"Donaghue KC","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"e_1_2_10_19_1","volume-title":"Principles and practice of screening for disease","author":"Wilson JMG","year":"1968"},{"issue":"2","key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12020-022-03259-6","article-title":"Longitudinal trends in lipid profile in indian children and youth with type\u20101 diabetes: a 5\u2010year follow up from a single centre","volume":"79","author":"Oza C","year":"2023","journal-title":"Endocrine"},{"issue":"6","key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11883-022-01020-y","article-title":"Are clinicians aggressive enough in treating diabetes\u2010related hyperlipidemia in youth?","volume":"24","author":"Jackson S","year":"2022","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jpeds.2006.04.065","article-title":"Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study","volume":"149","author":"Kershnar AK","year":"2006","journal-title":"J Pediatr"},{"issue":"2","key":"e_1_2_10_23_1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2337\/diacare.29.02.06.dc05-0724","article-title":"Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross\u2010sectional data from the German diabetes documentation and quality management system (DPV)","volume":"29","author":"Schwab KO","year":"2006","journal-title":"Diabetes Care"},{"issue":"3","key":"e_1_2_10_24_1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.acap.2023.07.006","article-title":"Pediatric high blood pressure follow\u2010up guideline adherence in a Massachusetts health care system","volume":"24","author":"Goulding M","year":"2024","journal-title":"Acad Pediatr"},{"issue":"4","key":"e_1_2_10_25_1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00125-007-0921-8","article-title":"High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population\u2010based study","volume":"51","author":"Margeirsdottir HD","year":"2008","journal-title":"Diabetologia"},{"key":"e_1_2_10_26_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpeds.2016.08.003","article-title":"Correlates of achieving statin therapy goals in children and adolescents with dyslipidemia","volume":"178","author":"Mendelson MM","year":"2016","journal-title":"J Pediatr"},{"issue":"2","key":"e_1_2_10_27_1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/diacare.28.2.337","article-title":"Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change","volume":"28","author":"Grant RW","year":"2005","journal-title":"Diabetes Care"},{"issue":"6","key":"e_1_2_10_28_1","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/HYPERTENSIONAHA.120.15721","article-title":"Vascular effects of ACE (angiotensin\u2010converting enzyme) inhibitors and statins in adolescents with type 1 diabetes","volume":"76","author":"Chiesa ST","year":"2020","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"7162","key":"e_1_2_10_29_1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bmj.317.7162.858","article-title":"Attributes of clinical guidelines that influence use of guidelines in general practice: observational study","volume":"317","author":"Grol R","year":"1998","journal-title":"The BMJ"},{"issue":"21","key":"e_1_2_10_30_1","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind M","year":"2014","journal-title":"N Engl J Med"},{"key":"e_1_2_10_31_1","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.696499","article-title":"Preventing cardiovascular complications in type 1 diabetes: the need for a lifetime approach","volume":"9","author":"Chiesa ST","year":"2021","journal-title":"Front Pediatr"}],"container-title":["Diabetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dme.70382","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dme.70382","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dme.70382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:50:21Z","timestamp":1782967821000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dme.70382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":30,"alternative-id":["10.1111\/dme.70382"],"URL":"https:\/\/doi.org\/10.1111\/dme.70382","archive":["Portico"],"relation":{},"ISSN":["0742-3071","1464-5491"],"issn-type":[{"value":"0742-3071","type":"print"},{"value":"1464-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"2025-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70382"}}